Wilmer Cutler Pickering Hale and Dorr represented Inozyme Pharma and Shearman & Sterling represented the underwriters in the offering. Inozyme Pharma, Inc. announced the closing of its...
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here